ACTION - (A) Select for download / view details OR (B)
Select two chains for comparison
|
|
Rank |
PDB ID |
Entity ID |
Chains |
Description |
Details |
Taxonomy |
EC Number |
1
|
5UCB
|
1
|
H
|
Fab Heavy Chain
|
|
9606
|
|
2
|
4HPY
|
1
|
H
|
CH59 Fab heavy chain
|
|
9606
|
|
3
|
4JG1
|
2
|
H
|
Fab heavy chain
|
|
9606
|
|
4
|
3KDM
|
2
|
B, H
|
Immunoglobulin heavy chain
|
|
9606
|
|
5
|
6AZM
|
2
|
B, D
|
580 germline antibody, heavy chain
|
Fragment: Fab
|
9606
|
|
6
|
6MVL
|
2
|
H
|
Antibody Fab fragment heavy chain
|
|
9606
|
|
7
|
5UEA
|
1
|
A, H
|
Fab Heavy Chain
|
|
9606
|
|
8
|
5TDN
|
2
|
B, D
|
anti-HER2 Fab Heavy Chain
|
|
9606
|
|
9
|
4JFZ
|
2
|
H
|
Fab heavy chain
|
|
9606
|
|
10
|
5U6A
|
2
|
B
|
Heavy Chain
|
|
9606
|
|
11
|
6APC
|
1
|
H
|
Epididymis luminal protein 214
|
|
9606
|
|
12
|
5UEK
|
2
|
H
|
Fab 12E Heavy Chain
|
|
9606
|
|
13
|
5IHZ
|
1
|
A, C, E, H
|
1E01 Fab fragment heavy chain
|
|
9606
|
|
14
|
5U3D
|
2
|
B
|
MEMAB TRASTUZUMAB FAB HEAVY CHAIN
|
|
9606
|
|
15
|
6BHZ
|
1
|
H, I
|
Trastuzumab Anti-HER2 Fab Heavy Chain
|
|
9606
|
|
16
|
6MY4
|
1
|
A, H
|
anti-VEGF-A Fab fragment bH1 heavy chain
|
|
9606
|
|
17
|
6BQB
|
2
|
H
|
MGG4 Fab heavy chain
|
|
9606
|
|
18
|
4PUB
|
1
|
H
|
DX-2930 HEAVY CHAIN
|
|
9606
|
|
19
|
6B14
|
1
|
H
|
Heavy chain of Fab BL3-6S97N
|
|
10090
|
|
20
|
5VKD
|
2
|
H
|
Fab Heavy Chain
|
|
9606
|
|
21
|
5XHG
|
2
|
B, D
|
polypeptide(H)
|
|
10090
|
|
22
|
6OTC
|
2
|
H
|
sFab H3 heavy chain
|
|
32630
|
|
23
|
6MY5
|
1
|
A, H
|
anti-VEGF-A Fab fragment bH1 heavy chain
|
|
9606
|
|
24
|
4JG0
|
2
|
H
|
Fab heavy chain
|
|
9606
|
|
25
|
5U5F
|
2
|
B
|
MEMAB TRASTUZUMAB FAB HEAVY CHAIN
|
|
9606
|
|
26
|
6BI2
|
1
|
H, I
|
Trastuzumab Anti-HER2 Fab Heavy Chain
|
|
9606
|
|
27
|
5F3B
|
1
|
A, E
|
RK35 Chimeric antibody heavy chain
|
|
10090
|
|
28
|
6B9Z
|
2
|
B
|
Trastuzumab Fab heavy chain
|
CSO is partially oxidized cysteine
|
10090
|
|
29
|
5TDO
|
2
|
B, D
|
anti-HER2 Fab Heavy Chain
|
|
9606
|
|
30
|
6U8D
|
2
|
H
|
Heavy chain of Fab HCV2
|
Heavy chain of Fab HCV2
|
9606
|
|
31
|
6PE7
|
1
|
H
|
FAB Heavy Chain
|
|
9606
|
|
32
|
3P0Y
|
2
|
H
|
Fab DL11 heavy chain
|
|
9606
|
|
33
|
5U5M
|
2
|
B
|
MEMAB TRASTUZUMAB, HEAVY CHAIN
|
|
9606
|
|
34
|
2V7N
|
2
|
B, D, F, H
|
IMMUNOGLOBULIN HEAVY CHAIN
|
SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL)
FAB FRAGMENT, RESIDUES 1-259
|
32630
|
|
35
|
5WUV
|
2
|
H
|
heavy chain
|
|
9606
|
|
36
|
5TDP
|
2
|
B, D
|
anti-HER2 Fab Heavy Chain
|
|
9606
|
|
37
|
6BAH
|
2
|
B
|
Trastuzumab Fab heavy chain,IGH@ protein
|
|
10090
|
|
38
|
6D0X
|
1
|
A
|
2140 Antibody, heavy chain
|
|
9606
|
|
39
|
1AQK
|
2
|
H
|
FAB B7-15A2
|
IMMUNOGLOBULIN HUMAN FAB
FAB
|
9606
|
|
40
|
6O39
|
2
|
B
|
Antibody F2.I Fab, Heavy chain
|
|
9606
|
|
41
|
5CSZ
|
1
|
A, H
|
GANTENERUMAB FAB FRAGMENT HEAVY CHAIN
|
FAB
|
9606
|
|
42
|
6GLW
|
2
|
C, H
|
Fab 1D11 - Heavy chain
|
|
9844
|
|
43
|
4H8W
|
2
|
H
|
FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5
|
|
9606
|
|
44
|
6GKU
|
2
|
H
|
Fab 6F5 - Heavy Chain
|
|
9844
|
|
45
|
5HI4
|
2
|
C, H
|
CAT-2000 FAB heavy chain
|
|
9606
|
|
46
|
5HI5
|
2
|
C, H
|
CAT-2000 FAB heavy chain
|
|
9606
|
|
47
|
4G5Z
|
1
|
H
|
canakinumab antibody fragment heavy chain
|
|
9606
|
|
48
|
3SOB
|
3
|
H
|
antibody heavy chain
|
|
9606
|
|
49
|
4JFX
|
2
|
B, H
|
Fab heavy chain
|
|
9606
|
|
50
|
4HJG
|
2
|
B
|
Trastuzumab heavy chain
|
|
9606
|
|
51
|
6B0W
|
2
|
H
|
1710 antibody, heavy chain
|
|
9606
|
|
52
|
6CBV
|
1
|
H
|
Heavy chain, Fab fragment
|
|
9606
|
|
53
|
4IOI
|
2
|
B
|
Trastuzumab heavy chain
|
|
9606
|
|
54
|
6GHG
|
1
|
A, H
|
Fab heavy chain
|
|
9606
|
|
55
|
6B0S
|
1
|
H
|
1710 antibody, heavy chain
|
|
9606
|
|
56
|
5GGQ
|
2
|
H
|
nivolumab heavy chain
|
|
9606
|
|
57
|
4OJF
|
1
|
H
|
Humanised 3D6 Fab Heavy Chain
|
|
10090
|
|
58
|
3GJF
|
5
|
H, M
|
Antibody heavy chain
|
|
9606
|
|
59
|
6MXR
|
1
|
A, H
|
anti-VEGF-A Fab fragment bH1 heavy chain
|
|
9606
|
|
60
|
2HFF
|
2
|
B, H
|
CB2 Fab, heavy chain
|
|
9606
|
|
61
|
6MXS
|
1
|
A, H
|
anti-VEGF-A Fab fragment bH1 heavy chain
|
|
9606
|
|
62
|
5GGV
|
2
|
H
|
heavy chain
|
|
9606
|
|
63
|
5D7S
|
2
|
H
|
Immunglobulin G1 Fab fragment, heavy chain
|
|
9606
|
|
64
|
4TSB
|
2
|
H
|
FAb Heavy Chain
|
|
9606
|
|
65
|
5BJZ
|
2
|
C, D
|
Synthetic antibody, Fab fragment, Heavy Chain
|
|
9606
|
|
66
|
2R8S
|
3
|
H
|
Fab heavy chain
|
|
10090
|
|
67
|
4HKZ
|
2
|
B
|
Trastuzumab heavy chain
|
|
9606
|
|
68
|
6DB8
|
1
|
H
|
Fab-Heavy chain
|
|
32630
|
|
69
|
5IG7
|
1
|
A, D, G, J
|
1E01 Fab fragment heavy chain
|
|
9606
|
|
70
|
6PHG
|
1
|
A
|
Germline 2544 Antibody Fab, Heavy Chain
|
|
9606
|
|
71
|
3SO3
|
3
|
C
|
A11 FAB heavy chain
|
|
9606
|
|
72
|
5BVJ
|
2
|
B, D, F, H
|
canakinumab Fab heavy-chain
|
|
9606
|
|
73
|
3TNN
|
1
|
A, C, E, H
|
Fab heavy chain of ADCC and non-neutralizing anti-HIV-1 antibody N5-i5
|
|
9606
|
|
74
|
6DKJ
|
1
|
A, H
|
Fab heavy chain
|
|
9606
|
|
75
|
4ZYK
|
1
|
A, H
|
AM14 Fab heavy chain
|
|
9606
|
|
76
|
6BLH
|
2
|
H
|
Fab CB017.5 heavy chain
|
|
9606
|
|
77
|
4TSC
|
2
|
H
|
FAb Heavy Chain
|
|
9606
|
|
78
|
5ITB
|
1
|
H
|
anti-RSV F Fab 14N4 Heavy chain
|
|
9606
|
|
79
|
6CW3
|
1
|
A, C
|
antibody heavy chain
|
|
9606
|
|
80
|
4XTR
|
2
|
C, E
|
Antibody Heavy chain
|
|
32630
|
|
81
|
5EA0
|
1
|
H
|
Heavy chain of antibody 7968 Fab fragment
|
|
9606
|
|
82
|
5TZU
|
2
|
H
|
Heavy Chain of Fab B6H12.2
|
|
9606
|
|
83
|
3PGF
|
2
|
H
|
SAB Heavy Chain
|
|
9606
|
|
84
|
5D70
|
2
|
H
|
Immunglobulin G1 Fab fragment, heavy chain
|
|
9606
|
|
85
|
6B9Y
|
2
|
B
|
Trastuzumab Fab heavy chain
|
|
9606
|
|
86
|
5I1A
|
2
|
B, H
|
CNTO388 HEAVY CHAIN
|
|
9606
|
|
87
|
2QQN
|
2
|
H
|
Antibody heavy chain
|
|
9606
|
|
88
|
6BAE
|
2
|
B
|
Trastuzumab Fab heavy chain
|
|
10090
|
|
89
|
4OGY
|
2
|
H, M
|
DX-2930 HEAVY CHAIN
|
|
9606
|
|
90
|
6BI0
|
1
|
H, I
|
Trastuzumab anti-HER2 Fab Heavy Chain
|
|
9606
|
|
91
|
3GRW
|
3
|
H
|
Fab heavy chain
|
|
9606
|
|
92
|
6B3K
|
1
|
H
|
Heavy chain of Fab BL3-6
|
|
10090
|
|
93
|
5I1D
|
2
|
B, H
|
FAB HEAVY CHAIN
|
|
9606
|
|
94
|
6AYZ
|
1
|
B, R
|
Fab Heavy Chain
|
|
9606
|
|
95
|
5WHJ
|
1
|
H
|
DX-2507 Fab heavy chain
|
|
9606
|
|
96
|
6O3A
|
2
|
B
|
Antibody F7.B Fab, Heavy chain
|
|
9606
|
|
97
|
4QHU
|
2
|
B, H
|
Fab6785 heavy chain
|
|
9606
|
|
98
|
4HIX
|
1
|
H
|
Humanized 3D6 Fab heavy chain
|
|
10090
|
|
99
|
1W72
|
4
|
H, I
|
HYB3 HEAVY CHAIN
|
FAB FRAGMENT, RESIDUES 1-211
|
9606
|
|
100
|
4KZD
|
1
|
H
|
BL3-6 Fab antibody, heavy chain
|
|
10090
|
|
101
|
6O1F
|
2
|
H
|
Heavy Chain hu31A.v11
|
|
9606
|
|
102
|
4XH2
|
1
|
A, C, E, G, H, J
|
Fab Heavy Chain
|
|
9606
|
|
103
|
6AXK
|
1
|
A
|
Fab311 heavy chain
|
|
9606
|
|
104
|
6R8X
|
3
|
C
|
anti-Factor-XI Fab fragment heavy chain MAA868
|
|
32644
|
|
105
|
3S34
|
2
|
H
|
1121B Fab heavy chain
|
|
10090
|
|
106
|
6J6Y
|
2
|
B, E
|
Fab Heavy chain
|
|
32630
|
|
107
|
6B6Z
|
2
|
B, D
|
Apo Fab Heavy Chain
|
|
9606
|
|
108
|
6NMS
|
2
|
B, H
|
Fab 136 anti-SIRP-alpha antibody Variable Heavy Chain
|
|
9606
|
|
109
|
5HI3
|
2
|
C, H
|
CAT-2000 FAB heavy chain
|
|
9606
|
|
110
|
6CNR
|
2
|
H
|
Aducanumab heavy chain
|
|
9606
|
|
111
|
5OCA
|
3
|
H
|
Fab from LDLR competitive antibody: Heavy chain
|
|
9606
|
|
112
|
4G6J
|
2
|
H
|
heavy chain of antibody binding fragment of canakinumab
|
heavy chain of antibody binding fragment of canakinumab
|
9606
|
|
113
|
5BVP
|
1
|
H
|
canakinumab Fab heavy-chain
|
|
9606
|
|
114
|
3G6A
|
2
|
B, H
|
CNTO607 Fab Heavy chain
|
|
9606
|
|
115
|
3PNW
|
2
|
B, E, H, K, N, Q, T, W
|
FAB heavy chain
|
|
32630
|
|
116
|
5D71
|
2
|
H
|
Immunglobulin G1 Fab fragment, heavy chain
|
|
9606
|
|
117
|
6DB9
|
2
|
H
|
Fab-Heavy-Chain
|
|
32630
|
|
118
|
4ZFG
|
2
|
H
|
Fragment antigen binding 5A12 heavy chain
|
|
9606
|
|
119
|
2R0L
|
2
|
H
|
antibody heavy chain, Fab portion only
|
|
32630
|
|
120
|
5BK1
|
1
|
C, H
|
Synthetic antibody, Fab fragment, Heavy Chain
|
|
9606
|
|
121
|
3GIZ
|
2
|
H
|
Fab fragment of anti-CD20 antibody Ofatumumab, heavy chain
|
|
9606
|
|
122
|
5HHV
|
2
|
H
|
CAT-2000 FAB heavy chain
|
|
9606
|
|
123
|
5VZ1
|
2
|
B, D
|
Apo Antibody Fab Heavy Chain
|
|
9606
|
|
124
|
3KR3
|
2
|
H
|
antibody-Fab (heavy chain)
|
|
9606
|
|
125
|
6DZN
|
2
|
H
|
Antibody ADI-15878, heavy chain
|
|
9606
|
|
126
|
6NEX
|
2
|
H
|
Antigen binding fragment heavy chain
|
|
10090
|
|
127
|
6NEX
|
4
|
B
|
Ighg protein
|
The lysines are reductively methylated MLY: is a reductively methylated lisine
|
10090
|
|
128
|
5GGU
|
1
|
A, H
|
heavy chain
|
|
9606
|
|
129
|
5W2B
|
1
|
H
|
Fab Heavy Chain
|
|
9606
|
|
130
|
3H42
|
4
|
H
|
Fab from LDLR competitive antibody: Heavy chain
|
|
9606
|
|
131
|
6PZH
|
2
|
B, H
|
NA-22 Fab heavy chain
|
|
9606
|
|
132
|
6CO3
|
2
|
H
|
Fab heavy chain
|
|
9606
|
|
133
|
4QF1
|
1
|
A, H
|
CH59UA Fab fragment of heavy chain
|
|
9606
|
|
134
|
3L95
|
2
|
B, H
|
anti-NRR1 fab fragment heavy chain
|
|
9606
|
|
135
|
4OGX
|
2
|
H
|
DX-2930 HEAVY CHAIN
|
|
9606
|
|
136
|
3UTZ
|
2
|
B, C, F
|
Metalloproteinase, heavy chain
|
|
10090
|
|
137
|
5WHK
|
1
|
H
|
DX-2507 Fab heavy chain
|
|
9606
|
|
138
|
4KZE
|
1
|
H
|
BL3-6 Fab antibody, heavy chain
|
|
10090
|
|
139
|
5WT9
|
1
|
H
|
Heavy Chain of Nivolumab
|
|
9606
|
|
140
|
4XVU
|
2
|
C, E, I, K
|
Antibody heavy chain
|
|
32630
|
|
141
|
4Q9Q
|
1
|
H
|
Fab BL3-6, HEAVY CHAIN
|
|
10090
|
|
142
|
5I1C
|
2
|
H
|
FAB HEAVY CHAIN
|
|
9606
|
|
143
|
5VZY
|
1
|
H
|
Crenezumab Fab heavy chain,Immunoglobulin gamma-1 heavy chain
|
|
9606
|
|
144
|
4WV1
|
2
|
B, E
|
Fab heavy chain
|
|
9606
|
|
145
|
5EII
|
1
|
A, H
|
Fab Heavy Chain
|
|
9606
|
|
146
|
1NL0
|
2
|
H
|
anti-factor IX antibody, 10C12, chain H
|
|
9606
|
|
147
|
4UB0
|
1
|
H
|
IgG1, heavy chain
|
|
9606
|
|
148
|
1FVD
|
2
|
B, D
|
IGG1-KAPPA 4D5 FAB (HEAVY CHAIN)
|
|
9606
|
|
149
|
1BJ1
|
2
|
H, K
|
Fab fragment, heavy chain
|
HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY
|
10090
|
|
150
|
5I1H
|
2
|
H
|
FAB HEAVY CHAIN
|
|
9606
|
|
151
|
6BFT
|
2
|
A, H
|
Avastin Heavy Chain Fab fragment mutant
|
|
9606
|
|
152
|
5IFJ
|
1
|
A, D, G, J
|
1E01 Fab fragment heavy chain
|
|
9606
|
|
153
|
5BV7
|
5
|
C
|
Fab1 heavy chain
|
|
9606
|
|
154
|
4K94
|
2
|
H
|
Fab19 light chain
|
|
9606
|
|
155
|
4NKI
|
1
|
H
|
Fab light chain
|
|
9606
|
|
156
|
5VEB
|
1
|
A, H
|
anti-CDH6 Fab heavy chain
|
|
9606
|
|
157
|
5VZX
|
1
|
E, H
|
Crenezumab Fab heavy chain
|
|
9606
|
|
158
|
5F6I
|
1
|
B
|
DH428 Antibody Heavy Chain
|
|
9544
|
|
159
|
5WAW
|
2
|
H
|
fAb Heavy Chain
|
|
9606
|
|
160
|
4TTD
|
2
|
C, H
|
FAb Heavy Chain
|
|
9606
|
|
161
|
5E08
|
1
|
H
|
Fab Heavy Chain
|
|
9606
|
|
162
|
6AZ2
|
1
|
A, C
|
Fab Heavy Chain
|
|
9606
|
|
163
|
1CZ8
|
3
|
H, Y
|
HEAVY CHAIN OF NEUTRALIZING ANTIBODY
|
MUTATED FORM OF A HUMANIZED MURINE ANTIBODY HEAVY CHAIN
|
10090
|
|
164
|
3GJE
|
2
|
B, H
|
Fab Heavy Chain
|
|
9606
|
|
165
|
5OCC
|
2
|
H
|
6G08 Fab heavy chain
|
|
9606
|
|
166
|
3HR5
|
2
|
B, H, I, J
|
Fab h47H4 heavy chain
|
|
10090
|
|
167
|
1FVE
|
2
|
B, D
|
IGG1-KAPPA 4D5 FAB (HEAVY CHAIN)
|
|
9606
|
|
168
|
4XWG
|
2
|
H
|
Fab1 Heavy Chain
|
|
9606
|
|
169
|
6PHH
|
1
|
A, C
|
2544 Antibody Fab, Heavy Chain
|
|
9606
|
|
170
|
2H9G
|
2
|
B, H
|
Fab BdF1, heavy chain
|
Fab fragment
|
9606
|
|
171
|
4G7V
|
1
|
H
|
fragment antibody heavy chain
|
|
9606
|
|
172
|
4O9H
|
2
|
H
|
Heavy Chain of the Camelid Fab fragment 61H7
|
|
9844
|
|
173
|
6NMU
|
2
|
B, H
|
Fab 115 anti-SIRP-alpha antibody Variable Heavy Chain
|
|
9606
|
|
174
|
3INU
|
1
|
H, M
|
KZ52 antibody fragment heavy chain
|
|
9606
|
|
175
|
5EU7
|
2
|
E, F
|
FAB Heavy Chain
|
|
9606
|
|
176
|
1DFB
|
2
|
H
|
IGG1-KAPPA 3D6 FAB (HEAVY CHAIN)
|
|
9606
|
|
177
|
5KG9
|
1
|
A, H
|
Antibody RE505-22 Fab heavy chain
|
|
10090
|
|
178
|
5X8M
|
2
|
B
|
durvalumab heavy chain
|
|
9606
|
|
179
|
6NFN
|
2
|
B, D, F, H, J, N, P, R
|
Fab h2E2 heavy chain
|
|
10090
|
|
180
|
4JFY
|
2
|
B, H
|
Fab heavy chain
|
|
9606
|
|
181
|
3BDY
|
1
|
H
|
Fab Fragment -Heavy Chain
|
|
9606
|
|
182
|
3K2U
|
3
|
H
|
Antibody, Fab fragment, Heavy Chain
|
|
9606
|
|
183
|
2HFG
|
2
|
H
|
CB3s Fab heavy chain
|
|
9606
|
|
184
|
4JQI
|
2
|
H
|
Fab30 heavy chain
|
|
10090
|
|
185
|
6U8C
|
3
|
D, H
|
Antibody heavy chain Fab
|
|
9606
|
|
186
|
3U30
|
3
|
C, F
|
Heavy chain Fab
|
|
9606
|
|
187
|
6B0A
|
1
|
H
|
1269 antibody, heavy chain
|
|
9606
|
|
188
|
2FJF
|
2
|
B, D, F, H, I, K, N, P, R, T, V, X
|
Heavy Chain of a VEGF binding Antibody
|
|
9606
|
|
189
|
6U8K
|
2
|
D, F, H
|
Heavy chain of Fab HCV3
|
Heavy chain of Fab HCV3
|
9606
|
|
190
|
5I1E
|
2
|
H
|
FAB HEAVY CHAIN
|
|
9606
|
|
191
|
2NYY
|
3
|
D
|
CR1 monoclonal antibody
|
heavy chain
|
9606
|
|
192
|
2GCY
|
2
|
B
|
huC25 fab fragment heavy chain
|
|
10090
|
|
193
|
2QQK
|
2
|
H
|
Antibody Heavy Chain
|
|
9606
|
|
194
|
4RRP
|
2
|
G, H, I, J, K, L
|
Fab antibody, heavy chain
|
|
9606
|
|
195
|
6JC2
|
1
|
H
|
ipilimumab fab heavy chain
|
|
9606
|
|
196
|
4XGZ
|
1
|
A, C, E, G, H, J, M, O, Q, S, U, W
|
FAB HEAVY CHAIN
|
|
9606
|
|
197
|
1N8Z
|
2
|
B
|
Herceptin Fab (antibody) - heavy chain
|
|
10090
|
|
198
|
5BK2
|
2
|
C, H
|
sAB Heavy Chain
|
|
9606
|
|
199
|
1TZH
|
3
|
B, H
|
Fab YADS1 Heavy Chain
|
|
10090
|
|
200
|
5BO1
|
2
|
H, I
|
Fab heavy chain
|
|
9606
|
|
201
|
6FOE
|
1
|
A, H
|
Fab BaxB01 heavy chain
|
engineered Fab binds oxidized macrophage migration inhibitory factor (MIF)
|
9606
|
|
202
|
4M6O
|
2
|
H
|
CNTO7309 heavy chain
|
FD
|
9606
|
|
203
|
6MWN
|
2
|
C, H
|
Fab HAVx Heavy Chain
|
Antibody fragment (Fab) that binds to domain V of Hepatitis A Virus IRES
|
9606
|
|
204
|
3EYQ
|
2
|
D
|
8f9 Fab
|
|
9606
|
|
205
|
6PI7
|
3
|
C, F
|
Fab antigen-binding fragment
|
|
9606
|
|
206
|
5BK3
|
2
|
A, C, E, H
|
580 Antibody, heavy chain
|
|
9606
|
|
207
|
4XWO
|
2
|
C, E, I, K, O, Q, U, W
|
Antibody heavy chain
|
|
32630
|
|
208
|
2VXS
|
2
|
H, I, J, K
|
FAB FRAGMENT
|
|
9606
|
|
209
|
4ZFF
|
1
|
A, H
|
Fragment antigen binding (Fab) 5A12 Heavy chain
|
|
9606
|
|
210
|
4XXD
|
2
|
B, E
|
Fab Heavy Chain
|
|
9606
|
|
211
|
6BGT
|
3
|
B
|
Herceptin heavy chain Fab fragment mutant
|
|
9606
|
|
212
|
3DVG
|
2
|
B
|
Human IgG1 fab fragment heavy chain
|
|
9606
|
|
213
|
4TSA
|
2
|
H
|
FAb Heavy Chain
|
|
9606
|
|
214
|
2FJG
|
3
|
B, H
|
Fab heavy chain
|
|
9606
|
|
215
|
4DKF
|
2
|
H, I
|
FAb2 Heavy Chain
|
|
9606
|
|
216
|
5TLK
|
4
|
D, H
|
H2191 HEAVY CHAIN
|
|
10090
|
|
217
|
3EFD
|
2
|
H
|
FabH
|
|
10090
|
|
218
|
4LF3
|
2
|
B, E
|
Fab light chain
|
|
10090
|
|
219
|
5HHX
|
2
|
H
|
CAT-2000 FAB heavy chain
|
|
9606
|
|
220
|
5D72
|
2
|
H, M
|
Immunglobulin G1 Fab fragment, heavy chain
|
|
9606
|
|
221
|
5WI9
|
3
|
F, H
|
39F7 Fab heavy chain
|
|
9606
|
|
222
|
6PZF
|
3
|
F, H
|
NA-63 Fab heavy chain
|
|
9606
|
|
223
|
6O3B
|
2
|
B, G
|
Antibody Fab F6, Heavy chain
|
|
9606
|
|
224
|
5F3H
|
1
|
A, C, E, G
|
humanized RK35 antibody heavy chain
|
|
10090
|
|
225
|
4G7Y
|
1
|
H
|
Fragment antibody heavy chain
|
|
9606
|
|
226
|
3DVN
|
2
|
B, H
|
Human IgG1 fab fragment heavy chain
|
|
9606
|
|
227
|
5I1I
|
2
|
H
|
FAB HEAVY CHAIN
|
|
9606
|
|
228
|
4NNP
|
2
|
H, X
|
Heavy chain of antagonistic fab fragment
|
|
9606
|
|
229
|
4ERS
|
2
|
H
|
Fab heavy chain
|
|
9606
|
|
230
|
2WUC
|
3
|
H
|
FAB FRAGMENT FAB40.DELTATRP HEAVY CHAIN
|
|
9606
|
|
231
|
6PE8
|
1
|
A, H
|
FAB Heavy chain
|
|
9606
|
|
232
|
5F6H
|
2
|
I, K, M, O
|
DH427 Antibody Heavy Chain
|
|
9544
|
|
233
|
6CYF
|
3
|
D, F, M, U
|
IgG1 antibody, heavy chain fragment
|
|
9606
|
|
234
|
6PHC
|
2
|
A, C
|
2544 Antibody Fab, Heavy Chain
|
|
9606
|
|
235
|
4K8R
|
5
|
H
|
Fab3H42, heavy chain
|
|
9606
|
|
236
|
3HAE
|
5
|
H, I, O, T
|
Antibody heavy chain
|
|
9606
|
|
237
|
6HHC
|
2
|
H
|
FXIA ANTIBODY FAB HEAVY CHAIN
|
|
9606
|
|
238
|
1TZI
|
2
|
B
|
Fab YADS2 Heavy Chain
|
|
10090
|
|
239
|
6JJP
|
1
|
A, D
|
Heavy chain of MW11-h317
|
|
9606
|
|
240
|
1MHP
|
2
|
H, X
|
Fab fragment, heavy chain
|
|
10090
|
|
241
|
3NH7
|
1
|
H, I, J, K
|
Antibody fragment Fab AbD1556, heavy chain
|
|
9606
|
|
242
|
3R1G
|
2
|
H
|
FAB of YW412.8.31 antibody heavy chain
|
|
9606
|
|
243
|
5I1G
|
2
|
H
|
FAB HEAVY CHAIN
|
|
9606
|
|
244
|
2QQL
|
2
|
H
|
Antibody Heavy Chain
|
|
9606
|
|
245
|
3WD5
|
3
|
H
|
Adalimumab Heavy Chain
|
|
9606
|
|
246
|
2WUB
|
3
|
H, R
|
FAB FRAGMENT FAB40.DELTATRP HEAVY CHAIN
|
|
9606
|
|
247
|
5TRU
|
2
|
H, h
|
Ipilimumab Fab heavy chain
|
|
9606
|
|
248
|
6NMR
|
2
|
A, F, H, J
|
Fab 119 anti-SIRP-alpha antibody Variable Heavy Chain
|
|
9606
|
|
249
|
6CW2
|
3
|
A
|
antibody heavy chain
|
|
9606
|
|
250
|
3BE1
|
2
|
H
|
Fab Fragment-Heavy Chain
|
|
9606
|
|
251
|
2FJH
|
3
|
B, H
|
Fab fragment heavy chain
|
|
9606
|
|
252
|
5XEZ
|
2
|
C, H
|
Antibody, mAb1, heavy chain
|
|
9606
|
|
253
|
4K9E
|
2
|
H
|
heavy chain
|
|
10090
|
|
254
|
3P0V
|
2
|
H, I
|
Fab DL11 heavy chain
|
|
9606
|
|
255
|
6FG2
|
1
|
D, F
|
HEAVY CHAIN FAB NAA84
|
|
9606
|
|
256
|
5WUX
|
1
|
A, C, H
|
heavy
|
|
9606
|
|
257
|
4I18
|
2
|
A, H
|
antibody heavy chain
|
Fab
|
10090
|
|
258
|
4Q9R
|
1
|
H
|
Fab BL3-6, HEAVY CHAIN
|
|
10090
|
|
259
|
4OQT
|
3
|
H
|
Heavy Chain of Li81 Fab, VH3-23
|
|
9606
|
|
260
|
3IVK
|
2
|
A, H
|
Fab heavy chain
|
man
|
10090
|
|
261
|
5I19
|
2
|
H
|
FAB HEAVY CHAIN
|
|
9606
|
|
262
|
5X8L
|
3
|
F, G, H, J, S
|
atezolizumab heavy chain
|
|
9606
|
|
263
|
6FGB
|
4
|
H
|
1519.g57- Heavy chain
|
|
9606
|
|
264
|
5GZN
|
2
|
C, H
|
Antibody Heavy chain
|
|
9606
|
|
265
|
5W4L
|
3
|
F, H
|
Antibody N5-i5 Fab heavy chain
|
|
9606
|
|
266
|
6D01
|
1
|
A, C, E, G
|
1210 Antibody, heavy chain
|
|
9606
|
|
267
|
5XF1
|
2
|
C, H
|
Antibody mAb1 Heavy chain
|
|
9606
|
|
268
|
4P59
|
2
|
H
|
MOR09825 Fab fragment heavy chain
|
|
9606
|
|
269
|
5XXY
|
1
|
H
|
heavy chain of atezolizumab fab
|
|
9606
|
|
270
|
5CJO
|
2
|
H
|
FAB Heavy chain with engineered elbow
|
|
10090
|
|
271
|
3N85
|
3
|
H
|
Fab37 Heavy Chain
|
|
9606
|
|
272
|
3G6J
|
4
|
F, H
|
Fab heavy chain
|
|
9606
|
|
273
|
5C7X
|
2
|
H, M
|
Immunglobulin G1 Fab fragment, heavy chain
|
|
9606
|
|
274
|
6MH2
|
2
|
B, D
|
Herceptin Fab arm heavy chain
|
|
9606
|
|
275
|
6DC3
|
1
|
H
|
Fab RSD5-Germline Heavy Chain
|
|
9606
|
|
276
|
6PE9
|
1
|
A, C, E, H, K
|
FAB Heavy chain
|
|
9606
|
|
277
|
4DKE
|
2
|
H, I
|
FAb1.1 Heavy Chain
|
|
9606
|
|
278
|
3G6D
|
2
|
H
|
CNTO607 Fab Heavy chain
|
|
9606
|
|
279
|
5USL
|
2
|
B, H
|
Fab vv304 Heavy chain
|
|
9606
|
|
280
|
6II8
|
3
|
G, H, J
|
Heavy chain of L4B-18 Fab
|
|
9606
|
|
281
|
5TPN
|
2
|
H
|
hRSV90 heavy chain
|
|
9606
|
|
282
|
3S37
|
2
|
H
|
1121B Fab heavy chain
|
|
10090
|
|
283
|
5XHF
|
2
|
B, D
|
polypeptide (H chain)
|
|
10090
|
|
284
|
5VL7
|
3
|
H
|
Fab33 heavy chain
|
|
9606
|
|
285
|
4NYL
|
2
|
A, C, E, H
|
Adalimumab Heavy Chain
|
|
9606
|
|
286
|
5GGR
|
1
|
A, H
|
heavy chain
|
|
9606
|
|
287
|
4XX1
|
2
|
E, H, M
|
Fab1 heavy chain
|
|
9606
|
|
288
|
5HJ3
|
3
|
A, E, I, M
|
KZ52 Antibody Fragment
|
|
9606
|
|
289
|
6II4
|
3
|
E, H
|
Heavy chain of L4A-14 Fab
|
|
9606
|
|
290
|
1ZA3
|
2
|
B, H
|
Fab-YSd1 heavy chain
|
Fab heavy chain
|
9606
|
|
291
|
5XHV
|
2
|
H, P
|
S40 heavy chain
|
|
9606
|
|
292
|
4IOF
|
2
|
C, E
|
Fab-bound IDE, heavy chain
|
|
10090
|
|
293
|
5CUS
|
2
|
H, I, J, K
|
IgG H chain
|
|
9606
|
|
294
|
4M1C
|
2
|
C, E
|
Fab-bound IDE, heavy chain
|
|
9606
|
|
295
|
5UOE
|
2
|
H, M, P, S, V
|
FAB Heavy chain with engineered elbow
|
|
9606
|
|
296
|
6APD
|
4
|
J, K, N
|
Immunoglobulin heavy variable 3-21,Immunoglobulin gamma-1 heavy chain
|
|
9606
|
|
297
|
2NZ9
|
3
|
D, F
|
AR2 monoclonal antibody
|
heavy chain
|
9606
|
|
298
|
3S36
|
2
|
H
|
1121B heavy chain
|
|
10090
|
|
299
|
5CWS
|
2
|
B, H
|
sAB-158 Fab Heavy Chain
|
|
9606
|
|
300
|
2R0K
|
3
|
H
|
antibody heavy chain of Fab58, Fab portion only
|
|
9606
|
|
301
|
3CSY
|
1
|
A, C, E, G
|
Fab KZ52 heavy chain
|
heavy chain
|
9606
|
|
302
|
5C8J
|
1
|
A, C, E, G
|
Antibody fragment, heavy chain
|
OBTAINED BY PHAGE DISPLAY FROM A LIBRARY OF HUMAN IGG. ANTIBODY FRAGMENT; THE CDRS ARE COMPLETELY SYNTHETIC
|
9606
|
|
303
|
4G80
|
2
|
A, C, E, G
|
fragment antibody heavy chain
|
|
9606
|
|
304
|
3P11
|
1
|
H
|
Fab DL11 heavy chain
|
|
9606
|
|
305
|
3F12
|
2
|
B, D
|
8f9 Fab
|
|
9606
|
|
306
|
3D69
|
2
|
B, H
|
anti-factor IX antibody, 10C12
|
|
9606
|
|
307
|
6ATT
|
2
|
H
|
Antibody 39S Fab heavy chain
|
Vh and Ch1 domains of antibody heavy chain
|
9606
|
|
308
|
5WOB
|
3
|
I, K, M, O, Q, S, U, W
|
IDE-bound Fab heavy chain
|
|
60742
|
|
309
|
5TLJ
|
4
|
D, H
|
M2191 HEAVY CHAIN
|
|
10090
|
|
310
|
2QR0
|
2
|
B, F, H, L, N, R, T, X
|
Fab-Fragment Heavy Chain
|
|
9606
|
|
311
|
5J3D
|
1
|
A, C, H
|
14N4 heavy chain
|
|
9606
|
|
312
|
3EFF
|
2
|
B, D
|
FAB
|
|
10090
|
|
313
|
3PJS
|
2
|
B, D
|
FAB heavy chain
|
|
10090
|
|
314
|
4ZYP
|
4
|
D, F, H
|
AM14 antibody Fab heavy chain
|
|
9606
|
|
315
|
5V2A
|
4
|
H
|
Heavy chain of H7.167 antibody
|
Fab
|
9606
|
|
316
|
6EA7
|
3
|
H, M, Q
|
ADI-15878 Fab Heavy Chain
|
|
9606
|
|
317
|
6EA5
|
3
|
H, M, Q
|
ADI-15878 Fab Heavy Chain
|
|
9606
|
|
318
|
5ZXV
|
2
|
C, H
|
heavy chain
|
|
9606
|
|
319
|
5F6J
|
3
|
B, H
|
DH427 Antibody Heavy Chain
|
|
9544
|
|
320
|
4XMN
|
7
|
H
|
Antibody 87 heavy chain
|
|
32630
|
|
321
|
4XMM
|
7
|
H
|
Antibody 57 heavy chain
|
|
9606
|
|
322
|
6UKJ
|
2
|
H
|
Fab Heavy Chain
|
|
9606
|
|
323
|
6U02
|
3
|
D, G, H, K
|
Fab-63 Heavy Chain
|
|
9606
|
|
324
|
6PZW
|
3
|
F, H, J, K
|
NA-22 fragment antigen binding heavy chain
|
|
9606
|
|
325
|
6PWC
|
4
|
H
|
Fab30 heavy chain
|
|
32630
|
|
326
|
6OT0
|
6
|
H
|
Fab heavy chain
|
|
10090
|
|
327
|
6OGE
|
5
|
E
|
Trastuzumab FAB HEAVY CHAIN
|
|
9606
|
|
328
|
6NI2
|
3
|
H
|
Fab30 Heavy Chain
|
|
32630
|
|
329
|
6MHG
|
2
|
A, B, C, D, F, G, H, I, J, K, M
|
Fab311 heavy chain
|
|
9606
|
|
330
|
6MB3
|
2
|
A, B, C, D, F, G, H, I, J
|
Fab311 heavy chain
|
|
9606
|
|
331
|
6E1K
|
3
|
D, F
|
cat06 heavy chain
|
|
9606
|
|
332
|
6CMO
|
6
|
H
|
Fab Heavy chain
|
|
32630
|
|
333
|
6BF7
|
2
|
C, E
|
Fab H11-E heavy chain
|
|
10090
|
|
334
|
6BF9
|
2
|
C, E
|
Fab H11-E heavy chain
|
|
10090
|
|
335
|
6B7Z
|
2
|
C, E
|
FAB H11 heavy chain
|
|
10090
|
|
336
|
6B70
|
2
|
C, E
|
FAB H11-E heavy chain
|
|
10090
|
|
337
|
4C2I
|
3
|
H, M
|
HEAVY CHAIN FAB FRAGMENT OF ANTIBODY 1F4
|
|
9606
|
|